Clinical Overview > Condition/ Syndrome

You are looking at 1 - 2 of 2 items for :

  • Hyperparathyroidism (tertiary) x
Clear All
Maria Cabrer Endocrine Unit, Hospital Comarcal d’Inca, Inca, Spain

Search for other papers by Maria Cabrer in
Google Scholar
PubMed
Close
,
Guillermo Serra Endocrine Unit, Hospital Universitari Son Espases, Palma, Spain

Search for other papers by Guillermo Serra in
Google Scholar
PubMed
Close
,
María Soledad Gogorza Endocrine Unit, Hospital Universitari Son Espases, Palma, Spain

Search for other papers by María Soledad Gogorza in
Google Scholar
PubMed
Close
, and
Vicente Pereg Endocrine Unit, Hospital Universitari Son Espases, Palma, Spain

Search for other papers by Vicente Pereg in
Google Scholar
PubMed
Close

Summary

Chromosome 22q11.2 deletion syndrome (22q11.2DS) is a genetic syndrome that may present with hypocalcemia due to primary hypoparathyroidism (PH) at any age. We report a new diagnosis of 22q11.2DS in a 57-year-old man who presented with symptomatic hypocalcemia. It is important to consider genetic causes of hypocalcemia due to PH regardless of age.

Learning points:

  • It is important to discard genetic cause of primary hypoparathyroidism in a patient without autoimmune disease or prior neck surgery.

  • A new diagnosis of a hereditary disease has familial implications and needs genetic counselling.

  • It is also important to discard other syndrome’s comorbidities.

Open access
Elizabeth M Madill Department of Endocrinology and Diabetes, The Alfred Hospital, Melbourne, Victoria, Australia

Search for other papers by Elizabeth M Madill in
Google Scholar
PubMed
Close
,
Shamil D Cooray Department of Endocrinology and Diabetes, The Alfred Hospital, Melbourne, Victoria, Australia

Search for other papers by Shamil D Cooray in
Google Scholar
PubMed
Close
, and
Leon A Bach Department of Endocrinology and Diabetes, The Alfred Hospital, Melbourne, Victoria, Australia
Department of Medicine (Alfred), Monash University, Melbourne, Victoria, Australia

Search for other papers by Leon A Bach in
Google Scholar
PubMed
Close

Summary

Thyrotoxicosis is an under-recognised but clinically important complication of parathyroidectomy. We report a case of a 37-year-old man with tertiary hyperparathyroidism who initially developed unexplained anxiety, diaphoresis, tachycardia, tremor and hyperreflexia one day after subtotal parathyroidectomy. Thyroid biochemistry revealed suppressed thyroid stimulating hormone and elevated serum free T4 and free T3 levels. Technetium-99m scintigraphy scan confirmed diffusely decreased radiotracer uptake consistent with thyroiditis. The patient was diagnosed with thyrotoxicosis resulting from palpation thyroiditis. Administration of oral beta-adrenergic antagonists alleviated his symptoms and there was biochemical evidence of resolution fourteen days later. This case illustrates the need to counsel patients about thyroiditis as one of the potential risks of parathyroid surgery. It also emphasises the need for biochemical surveillance in patients with unexplained symptoms in the post-operative period and may help to minimise further invasive investigations for diagnostic clarification.

Learning points

  • Thyroiditis as a complication of parathyroidectomy surgery is uncommon but represents an under-recognised phenomenon.

  • It is thought to occur due to mechanical damage of thyroid follicles by vigorous palpation.

  • Palpation of the thyroid gland may impair the physical integrity of the follicular basement membrane, with consequent development of an inflammatory response.

  • The majority of patients are asymptomatic, however clinically significant thyrotoxicosis occurs in a minority.

  • Patients should be advised of thyroiditis/thyrotoxicosis as a potential complication of the procedure.

  • Testing of thyroid function should be performed if clinically indicated, particularly if adrenergic symptoms occur post-operatively with no other cause identified.

Open access